ST316CRCNew York Medical Collegecolorectal cancerNYMC
…N)-MDSCs in peripheral blood (PB) of phase I patients following ST316 monotherapy. Here we explore the impact of ST316 on PMN-MDSC de…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 206 of 2459PLT012HCCliver cancer
…tases and resensitized tumors to anti-PD1 therapy. Importantly, PLT012 treatment not only elicited remarkable tumor-control immunity, …
GBMBDNFGlioblastomaSemaphorin-3CVEGF-CIL-10NRP2
…le-cell RNA sequencing and immunohistochemistry. C57BL/6 murine GBM models (CT-2A, SB28) were used to define mechanisms associated …
cisplatinoxaliplatinplatintriple negative breast canceranthracyclinechemotherapyimmunotherapyprophylactic vaccinationplatin-based chemotherapies
… in increased ATP release and calreticulin exposure compared to cisplatin.Conclusions We show the syngeneic orthotopic model of TNBC is a…
CRCMahidol Universitycancercolorectal cancerGlasgow Tissue Research FacilityNational Research Council of ThailandTB
…enchymal transition (EMT), TNF-α and TGF-β, in both independent CRC cohorts. Regional bulk RNA expression revealed that cell cycle …
AB598AB598-mediatedAB598-dosedzimberelimabadvanced solid tumorsGEJ cancermFOLFOXNCT05891171
…tics (PK), pharmacodynamics (PD), and clinical activity of both AB598 monotherapy and AB598 in combination with zimberelimab (anti-PD…
solid tumourshaematological malignanciesChimeric Antigen Receptor T (CAR-T) cell therapyEuropean Research CouncilERCanticancer drugsMinisterio de Educacion y Formacion ProfesionalHorizon 2020 research and innovation programmesolid tumorsICoMICS
…buting to the development of more effective immunotherapies for solid tumours.This work was supported by the European Research Council (ERC) …
Afamitresgene autoleucelafami-celadvanced synovial sarcomaAdaptimmune
…044768.Reference D’Angelo SP, Araujo DM, Abdul Razak AR, et al. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma…
lifileuceladvanced melanomaMassachusetts General HospitalDana-Farber/Harvard Cancer CentermelanomaMass General Cancer Center Tumor Cartography Centeradoptive T cell therapyDr. Miriam and Sheldon G. Adelson Medical Research Foundation
…ls. Using scRNA-seq and TCR-seq data from patients treated with lifileucel,3 we confirmed that tumoricidal TIL express high levels of LTB,…
cancerprostatecancer-free
…d common significant proteins (FDR <0.1) associated with future cancer risk…
EVOLVE104EIU-104101urothelial carcinomasquamous cell carcinomasCohort BCohort AFDAEVOLVE TCEstransitional cell carcinomas of the urinary tractlocally advanced or metastatic solid tumors
… the safety, efficacy, pharmacokinetics and pharmacodynamics of EVOLVE104 in subjects with locally advanced or metastatic solid tumors, r…
TU2218PembrolizumabECOG Performance StatusHNSCChead and neck squamous cell carcinoma (HNSCC)anti PD-(L)1 antibody
…ynx (25%), oral cavity (16.7%), hypopharynx (16.7%).Conclusions TU2218 in combination with Pembrolizumab in patients with HNSCC demons…